CCN3/NOV as a potential therapeutic target for diverticular disease: A proteome-wide Mendelian randomization study

Masahiro Yoshikawa,Kensuke Asaba

DOI: https://doi.org/10.1097/md.0000000000040467

IF: 1.6

2024-11-13

Medicine

Abstract:Diverticular disease (DD) of the intestine is a common condition marked by the presence of multiple sacs or pouches at weak points in the muscle layers of the bowel wall. [ 1 ] The prevalence of DD is <10% in individuals younger than 40 years old and more than 50% in those older than 80 years old; [ 2 ] however, the incidence is currently increasing in younger groups. [ 1 ] Most patients may be asymptomatic, but 10% to 25% of cases develop complications such as diverticulitis, hemorrhage, fistula formation, and perforation, [ 1 , 3 ] which require endoscopic or surgical therapies and can be a high burden. In addition to environmental factors, genetic predisposition is supposed to play an essential role in the pathogenesis of disease. [ 1 ] To date, genome-wide association studies (GWAS) have reported more than 100 genome-wide significant loci and candidate causal genes in the European population, inferring potential mechanisms of DD onset, such as dysregulation of wall structure, mortality, mucus, and membrane transport. [ 4–8 ] However, these studies were conducted at the transcriptional level. Effective therapies or preventions based on underlying disease mechanisms remain to be established.

medicine, general & internal